A detailed history of Van Hulzen Asset Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 186,608 shares of MRK stock, worth $18.6 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
186,608
Previous 209,589 10.96%
Holding current value
$18.6 Million
Previous $25.9 Million 18.33%
% of portfolio
1.53%
Previous 1.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $2.55 Million - $2.96 Million
-22,981 Reduced 10.96%
186,608 $21.2 Million
Q2 2024

Aug 07, 2024

BUY
$123.8 - $132.96 $110,429 - $118,600
892 Added 0.43%
209,589 $25.9 Million
Q1 2024

May 06, 2024

SELL
$113.24 - $131.95 $86,628 - $100,941
-765 Reduced 0.37%
208,697 $27.5 Million
Q4 2023

Feb 07, 2024

SELL
$100.18 - $109.02 $42,676 - $46,442
-426 Reduced 0.2%
209,462 $22.8 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $1.68 Million - $1.86 Million
16,300 Added 8.42%
209,888 $21.6 Million
Q2 2023

Aug 03, 2023

BUY
$108.61 - $118.38 $1.65 Million - $1.8 Million
15,183 Added 8.51%
193,588 $22.3 Million
Q1 2023

Apr 28, 2023

BUY
$102.94 - $114.86 $2.51 Million - $2.8 Million
24,402 Added 15.85%
178,405 $19 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $3.22 Million - $4.12 Million
-36,792 Reduced 19.28%
154,003 $17.1 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $1.22 Million - $1.37 Million
14,418 Added 8.17%
190,795 $16.4 Million
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $1.32 Million - $1.5 Million
15,800 Added 9.84%
176,377 $16.1 Million
Q1 2022

May 20, 2022

BUY
$73.51 - $82.4 $430,842 - $482,946
5,861 Added 3.79%
160,577 $13.2 Million
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $4.1 Million - $5.14 Million
56,785 Added 57.98%
154,716 $11.9 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $94,402 - $103,819
1,317 Added 1.36%
97,931 $7.36 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $168,744 - $186,648
2,400 Added 2.55%
96,614 $7.51 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $5.11 Million - $6.02 Million
74,245 Added 371.8%
94,214 $7.26 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $45,861 - $50,896
639 Added 3.31%
19,969 $1.63 Million
Q3 2020

Nov 03, 2020

BUY
$73.18 - $82.95 $28,247 - $32,018
386 Added 2.04%
19,330 $1.6 Million
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $48,589 - $55,289
690 Added 3.78%
18,944 $1.47 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $3,611 - $5,005
-57 Reduced 0.31%
18,254 $1.4 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $21,179 - $23,898
273 Added 1.51%
18,311 $1.67 Million
Q3 2019

Oct 30, 2019

SELL
$76.08 - $82.93 $46,484 - $50,670
-611 Reduced 3.28%
18,038 $1.52 Million
Q2 2019

Aug 08, 2019

BUY
$69.84 - $81.59 $176,625 - $206,341
2,529 Added 15.69%
18,649 $1.56 Million
Q1 2019

May 01, 2019

SELL
$69.58 - $79.36 $9.33 Million - $10.6 Million
-134,081 Reduced 89.27%
16,120 $1.34 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $673,537 - $781,630
-10,324 Reduced 6.43%
150,201 $11.5 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $257,528 - $302,837
4,464 Added 2.86%
160,525 $11.4 Million
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $288,714 - $339,209
-5,680 Reduced 3.51%
156,061 $9.47 Million
Q1 2018

May 08, 2018

BUY
$50.96 - $59.23 $4.24 Million - $4.93 Million
83,229 Added 106.01%
161,741 $8.81 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $3.89 Million - $4.64 Million
75,319 Added 2358.88%
78,512 $4.42 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $187,333 - $201,574
3,193
3,193 $204,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Van Hulzen Asset Management, LLC Portfolio

Follow Van Hulzen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.